SBI Securities’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

SBI Securities’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-24,626	Closed	-$6.08K	–	4175
2026 Q1	$6.08K	Buy	24,626 +85	+0.3%	+$34	﹤0.01%	1946
2025 Q4	$10.3K	Sell	24,541 -2	-0%	-$1	﹤0.01%	1716
2025 Q3	$16.5K	Sell	24,543 -1,711	-7%	-$922	﹤0.01%	1534
2025 Q2	$14.2K	Sell	26,254 -1,724	-6%	-$1.02K	﹤0.01%	1541
2025 Q1	$18.3K	Buy	27,978 +122	+0.4%	+$129	﹤0.01%	1364
2024 Q4	$28.4K	Buy	+27,856	New	+$50.9K	﹤0.01%	1198

Other funds holding SGMO

AIM

Axiom Investment Management New York $150M AUM

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

SBI Securities's SGMO Position: Q2 2026 in Review

SBI Securities sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 24,626 shares — an estimated $6.08K sold.

SBI Securities first reported a position in SGMO in Q4 2024 and held it in 6 quarters. The position peaked at $28.4K in Q4 2024. 2 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

SBI Securities reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
SBI Securities sold 24,626 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $6.08K.
SBI Securities first reported a position in SANGAMO THERAPEUTICS INC in Q4 2024 and held it in 6 quarters.
SBI Securities's SANGAMO THERAPEUTICS INC position peaked at $28.4K in Q4 2024.
2 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.